Novato, CA, United States
Novato, CA, United States

Time filter

Source Type

Patent
Ultragenyx Pharmaceutical | Date: 2016-09-14

The present invention includes crystalline forms of N-acetylneuraminic acid (NeuAc) and crystalline forms of salts and/or solvates of N-acetylneuraminic acid (NeuAc). Furthermore, the present invention provides compositions comprising these crystalline forms and therapeutic use of the crystalline forms.


Patent
Ultragenyx Pharmaceutical and Kyowa Hakko Kirin Co. | Date: 2015-05-29

The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.


Patent
Ultragenyx Pharmaceutical | Date: 2015-09-10

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2015-03-05

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2015-11-18

The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.


Patent
Ultragenyx Pharmaceutical | Date: 2014-08-15

The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.


The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM).


Patent
Ultragenyx Pharmaceutical | Date: 2014-11-05

The present invention provides novel creatine analogs useful for treating any creatine deficiency disorders and methods of treating and preventing creatine deficiencies utilizing the present compounds and the pharmaceutical compositions or formulations thereof. Certain embodiments seek to increase the lipophilicty of novel creatine analogs with the goal of improving their bioavailability.


Patent
Ultragenyx Pharmaceutical | Date: 2016-08-30

The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.


Patent
Ultragenyx Pharmaceutical | Date: 2014-11-14

The present invention includes solid compositions of triglycerides with one or more fatty acids, such as triheptanoin and glycerol phenylbutyrate, and therapeutic use thereof. The solid compositions can be prepared by spray-drying or other processes.

Loading Ultragenyx Pharmaceutical collaborators
Loading Ultragenyx Pharmaceutical collaborators